CCOS 2025: Ninestars Showcases Innovative Eye Health Solutions
- 2026-05-17
- Source：The Ninestars
From September 4 to 7, 2025, Beijing Ninestars participated in CCOS 2025 in Hangzhou, under the theme “Innovative Technology Leads the Future of Eye Health”. Our company’s world’s first Wide-Field Retinal Refractometry Topographer (VPR) attracted lots of ophthalmologists, optometrists and researchers both home and abroad to explore and study its advanced capabilities.
Besides of VPR, our booth also highlights four key solutions:
1. Myopia Prevention & Control
Home devices like Moon Phase Lens and Defocus Reading and Writing Device, and school solutions including automatic refractor and LCD visual acuity chart.
2. Digital Visual Training
In-hospital VR and 5D systems, plus home-based AR helmets for vision training.
3. Outpatient Examination
Advanced AI-assisted devices for basic and specialized exams, including fundus camera, tonometer, and ophthalmic biometer.
4. Dry Eye Diagnosis & Treatment
The newly launched HTP100 Hand-held Thermal Pulsation Device provides fast, portable, and customizable treatment for meibomian gland dysfunction.
During CCOS, Beijing Ninestars also hosted academic seminars featuring top experts and unveiled the HTP100 with company leadership and researchers. Through these innovations, Beijing Ninestars demonstrates its commitment to integrated, multi-scenario solutions—from screening and diagnosis to training—advancing eye health and supporting the Healthy China Initiative.
Besides of VPR, our booth also highlights four key solutions:
1. Myopia Prevention & Control
Home devices like Moon Phase Lens and Defocus Reading and Writing Device, and school solutions including automatic refractor and LCD visual acuity chart.
2. Digital Visual Training
In-hospital VR and 5D systems, plus home-based AR helmets for vision training.
3. Outpatient Examination
Advanced AI-assisted devices for basic and specialized exams, including fundus camera, tonometer, and ophthalmic biometer.
4. Dry Eye Diagnosis & Treatment
The newly launched HTP100 Hand-held Thermal Pulsation Device provides fast, portable, and customizable treatment for meibomian gland dysfunction.
During CCOS, Beijing Ninestars also hosted academic seminars featuring top experts and unveiled the HTP100 with company leadership and researchers. Through these innovations, Beijing Ninestars demonstrates its commitment to integrated, multi-scenario solutions—from screening and diagnosis to training—advancing eye health and supporting the Healthy China Initiative.
Recommended News
